Sanofi (SNY) Tax Provisions (2009 - 2026)

Sanofi has disclosed Tax Provisions across 18 years of filings, most recently posting -$524.2 million for Q2 2026.

• In Q2 2026, Tax Provisions fell 101.35% year-over-year to -$524.2 million; the TTM figure through Jun 2026 stood at -$3.9 billion (down 37.52% YoY), while the FY2025 annual figure was $1.2 billion, up 193.17% from the prior year.
• Tax Provisions came in at -$524.2 million for Q2 2026 at Sanofi, down from -$491.7 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of -$113.0 million in Q1 2024 to a low of -$1.9 billion in Q4 2022.
• Average Tax Provisions over 5 years is -$703.6 million, with a median of -$515.1 million recorded in 2025.
• Year-over-year, Tax Provisions jumped 77.07% in 2024 and plunged 347.82% in 2025.
• Over 5 years, Tax Provisions stood at -$1.9 billion in 2022, then jumped by 43.82% to -$1.1 billion in 2023, then decreased by 17.58% to -$1.3 billion in 2024, then increased by 5.63% to -$1.2 billion in 2025, then jumped by 56.82% to -$524.2 million in 2026.
• Per Business Quant data, the three most recent Tax Provisions figures were -$524.2 million in Q2 2026, -$491.7 million in Q1 2026, and -$1.2 billion in Q4 2025.